Skip to main content

Published locations for Baricitinib allows flexibility in dosing regimens up to 104 weeks in moderate-to-severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Baricitinib allows flexibility in dosing regimens up to 104 weeks in moderate-to-severe atopic dermatitis

User login

  • Reset your password
  • /content/baricitinib-allows-flexibility-dosing-regimens-104-weeks-moderate-severe-atopic-dermatitis
  • /dermatology/article/262442/atopic-dermatitis/baricitinib-allows-flexibility-dosing-regimens-104